Eli Lilly on Wednesday said its experimental combination regimen showed greater weight loss than a high dose of its top-selling drug, tirzepatide, alone in a mid-stage trial on patients with obesity and Type 2 diabetes.
Trading volumes for certain products on prediction market platforms Kalshi and Polymarket are raising questions from some industry observers, who fear the numbers may be inflated.
Consumer prices posted a smaller-than-expected increase in August from a year ago, according to the Federal Reserve's primary inflation gauge, the Commerce Department reported Wednesday.